Difficulty: Medium
Average Score: 70%
Practice
What is the first-line treatment for a neonate diagnosed with meconium aspiration syndrome (MAS)?
Correct answer
B
Rationale
In the management of a neonate diagnosed with meconium aspiration syndrome (MAS), the first-line treatment is positive pressure ventilation (Option B). This intervention is crucial in supporting the neonate's respiratory efforts and improving oxygenation in the presence of meconium obstructing the airways. Positive pressure ventilation helps to open collapsed alveoli, improve lung compliance, and prevent respiratory failure in these infants.
Surfactant therapy (Option A) is not the first-line treatment for MAS. While surfactant replacement therapy may be indicated in certain respiratory conditions, it is not the primary intervention for addressing meconium aspiration.
Antibiotics (Option C) are not indicated as the initial treatment for MAS unless there is a concurrent infection present. The primary focus in MAS management is on respiratory support rather than antimicrobial therapy.
Oxygen therapy (Option D) may be used in MAS to optimize oxygenation; however, it is not the first-line treatment. Positive pressure ventilation takes precedence in addressing the respiratory distress associated with meconium aspiration.
In an educational context, understanding the appropriate management of MAS is crucial for nurses caring for neonates in various clinical settings. By knowing the first-line treatment and rationale behind it, nurses can provide prompt and effective care to improve outcomes for infants with MAS. Additionally, this knowledge helps nurses prioritize interventions based on the specific needs of neonates with respiratory distress.
Surfactant therapy (Option A) is not the first-line treatment for MAS. While surfactant replacement therapy may be indicated in certain respiratory conditions, it is not the primary intervention for addressing meconium aspiration.
Antibiotics (Option C) are not indicated as the initial treatment for MAS unless there is a concurrent infection present. The primary focus in MAS management is on respiratory support rather than antimicrobial therapy.
Oxygen therapy (Option D) may be used in MAS to optimize oxygenation; however, it is not the first-line treatment. Positive pressure ventilation takes precedence in addressing the respiratory distress associated with meconium aspiration.
In an educational context, understanding the appropriate management of MAS is crucial for nurses caring for neonates in various clinical settings. By knowing the first-line treatment and rationale behind it, nurses can provide prompt and effective care to improve outcomes for infants with MAS. Additionally, this knowledge helps nurses prioritize interventions based on the specific needs of neonates with respiratory distress.